Morphological Assessment of Embryos in Culture

25
Morphological Assessment of Embryos in Culture


J. Diane Critchlow


Why Do We Select Embryos?


The purpose of embryo selection is to improve live birth rates per egg collection by maximizing use of all embryos with implantation potential, but to achieve low multiple pregnancy rates by reducing the number of fresh embryos transferred (Pandian et al. 2013). Selection of spare embryos for cryostorage and use in future cycles increases cumulative live birth rates (Glujovsky 2012).


Routine or ‘conventional’ embryo assessment is currently focused mainly on morphological criteria and cleavage rate during development. This is performed noninvasively at several predetermined microscopic evaluations during removal of the embryos from the incubator and continues to be the most widespread system in use (Gianaroli et al. 2000; Magli et al. 2012). However, this process may result in detrimental environmental stress and provides only a brief snapshot of embryo development. It must also be remembered that despite the best efforts of embryologists to select an embryo for transfer with the most potential, the process of implantation includes several factors that may not be directly related to the embryo, including receptivity of the endometrium (Evans et al. 2014). The ability of alternative screening technologies (preimplantation genetic screening (PGS), metabolomics, proteomics) has been evaluated in recent years, but has not yet superseded routine morphology assessment (Gleicher et al. 2014; Vergouw et al. 2014). Most recently, use of time‐lapse imaging (TLI) with formulation of morphokinetic algorithms to assess embryos has produced higher implantation rates (Meseguer et al. 2011; Basile et al. 2015), but improvements may be the result of undisturbed culture reducing embryo stress.


In the UK, it is policy for all clinics to reduce multiple birth rates to below 10% (HFEA) and the NICE Fertility Guidelines (2013) recommend elective single embryo transfer (eSET) in women who have at least one ‘top quality’ embryo. However, the lack of standardized embryo morphology grading systems in assisted reproductive technology clinics worldwide has made the definition of embryo ‘quality’ and comparison of studies very difficult. Recently, there has been a move towards standardization of grading schemes internationally (Cutting et al. 2008; Vernon et al. 2009; Racowsky et al. 2010; Alpha/ESHRE Istanbul Consensus 2011; Pons et al. 2014) and the development of external quality assessment (EQA) schemes (UK NEQAS) to assess interlaboratory performance and reduce operator subjectivity. However, while there is a certain amount of agreement on what constitutes a ‘top quality’ or a ‘poor’ embryo, it is more difficult to find a consensus between laboratories when attempting to evaluate intermediate quality embryos. The latter may be deselected from clinical use and yet may have implantation potential (Kirkegaard et al. 2014).


A Cochrane data review (Pandian et al. 2013) revealed that there is no evidence of a significant difference in the cumulative live birth rate when a single cycle of double embryo transfer is compared with repeated eSETs (fresh and frozen cycles), particularly in younger women. Improvement in cryostorage techniques and frozen embryo success rates seems to be leading to a change in thinking and questioning of embryo selection methods in fresh cycles (Gleicher et al. 2015). Extended culture to the blastocyst stage, rather than earlier cleavage stage transfer, has become increasingly integrated into routine clinical practice by many assisted reproductive technology centres worldwide. The ‘deselection’ of embryos by extended culture or by grading as ‘unsuitable’ for cryostorage may lead to loss of embryos which may have implantation potential. Indeed, an earlier Cochrane review showed that cumulative pregnancy rates from embryos transferred on Day 3 significantly outperformed transfers at blastocyst stage (Glujovsky et al. 2012). In the light of current information regarding possible compromised endometrial quality in stimulated cycles (Shapiro et al. 2011), there is strong evidence to suggest that IVF outcomes can be improved with the adoption of ‘freeze‐all’ or elective frozen embryo transfer (eFET) strategies (Evans et al. 2014; Roque et al. 2015). There is also evidence for improved neonatal outcomes in frozen cycles (Imudia et al. 2014). This may lead to a different emphasis being placed on embryo assessment and selection, particularly in fresh cycles.


This chapter will review the most widely used embryo assessment methods using morphological parameters at defined stages of culture postinsemination. Photomicrographic illustrations have not been included, but can be found in a recent extensive review (Magli et al. 2012).


Conventional Morphology Assessment


Assessment of Zygotes and Cleavage Stage Embryos


The most widely used morphological parameters have been cell number/rate of embryo development, cell size/cleavage evenness, and cell fragmentation. However, it will become clear in the sections below that assessment of each of these parameters can be subjective and interrelated. For example, large anuclear fragments may be mistaken for cells, which will in turn affect the accuracy of cell count, degree of fragmentation, and assessment of cell size/cleavage evenness. Nevertheless, early embryo selection based on morphology assessment improves implantation and pregnancy rates (De Placido et al. 2002; Vernon et al. 2009; Machtinger and Rackovsky 2013). Analysis of pronuclear (PN) morphology after fertilization and multinucleation (MN) scoring at the 2–4‐cell stage has also been widely used.


Pronuclear/Zygote Grading


The process of fertilization involves an ordered series of morphological changes that affect the appearance of the one cell zygote (Edwards and Beard 1999). Assessment at the zygote stage is also useful in countries where legislation requires that only a limited number of embryos may continue in culture prior to embryo transfer (Zollner et al. 2002; Senn et al. 2006); embryos considered to have the best implantation potential after PN grading are cultured for transfer and sibling zygotes are cryostored.


PN scoring involves assessment of the alignment of the PN and the number and relative position of the nucleolar precursor bodies (NPBs) in the PN. The most established methods of PN analysis have been described as Patterns 0–5 (Tesarik et al. 2000) and by Z scores 1–4 (Scott 2003), but with much variation between clinics. According to the Alpha/ESHRE Istanbul Consensus (2011), three grades for PN scoring are based on the morphology of NPBs and PNs: (1) symmetrical; (2) non‐symmetrical and; (3) abnormal (Table 25.1). As the processes associated with fertilization by IVF insemination lag behind fertilization using ICSI (Nagy et al. 2003), PN grading must be performed at a standardized time relative to insemination time, i.e. 17 + 1 h postinsemination (Alpha/ESHRE Istanbul Consensus 2011).


Table 25.1 Grading scheme for pronuclear stage embryo assessment (Alpha/ESHRE Istanbul Consensus 2011).




















Grade Rating Description
1 Symmetrical Zygotes presenting with equal numbers and size of NPBs, either aligned at the junction between PNs or scattered in both PNs.
2 Nonsymmetrical Comprises all other patterns including peripherally localized PNs.
3 Abnormal Single NPB or total absence of NPBs.

NPB, nucleolar precursor bodies; PN, pronuclei.


The value of PN scoring has been debated, with some studies showing a prognostic effect (Tesarik et al. 2000; Balaban et al. 2004; Zamora et al. 2011) and a correlation with aneuploidy (Gianaroli et al. 2003; Edirisinghe et al. 2005), or no prognostic value (James et al. 2006; Nicoli et al. 2010; Weitzman et al. 2010; Berger et al. 2014).


One of the main limitations of assessing the highly dynamic PN formation is having to use single and static observations. TLI systems may now be used to help define the timing for zygote assessment and the dynamic changes that occur, although the concept is not new (Payne et al. 1997). This may provide more information to solve discrepancies in the literature (Nicoli et al. 2013).


Early Cleavage Check


Checking embryos again on Day 1 (Table 25.2) for the time of syngamy (disappearance of PN) and first cleavage has been used by some laboratories as an additional tool in selecting embryos with high implantation potential and decreased chromosomal anomalies (Lawler et al. 2007; Hammoud et al. 2008).


Table 25.2 Recommended timings for early cleavage stage (Day 1) embryo assessment (Alpha/ESHRE Istanbul Consensus 2011).
















Observation Timing (Hours Postinsemination) Expected Stage of Development
Syngamy check 23 ± 1 h Up to 50% in syngamy
(up to 20% at the two‐cell stage)
Early cleavage check 26 ± 1 h post‐ICSI
28 ± 1 h post‐IVF
Two‐cell stage

ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization.


Early cleaving embryos have been reported to divide more evenly, which has been correlated with a lower incidence of chromosomal errors (Hardarson et al. 2001), and in eSETs with higher clinical pregnancy rates (Salumets et al. 2003), although precocious embryo development (cleavage earlier than 20 h postinsemination) gave a poorer prognosis. Although a recent review found no value in an early cleaving check (de los Santos et al. 2014), the use of TLI may prove a particularly powerful tool to assess early cleavage and subtle morphological changes without removal from the incubator (Lemmen et al. 2008). The visualization of anomalous events with TLI such as direct cleavage and reverse cleavage previously not possible with conventional static microscopy may be useful as deselection criteria. Direct cleavage has been shown to be associated with very low implantation rates (1.2%) in embryos dividing from one to three cells in less than 5 h (Rubio et al. 2012a).


Day 2 and Day 3 Stage Embryos


Morphological evaluation at cleavage stages has traditionally formed the basis for determining embryo quality, with the first live birth reported following transfer at this stage (Steptoe and Edwards 1978). Recommended timings for assessment are shown in Table 25.3. Blastocyst stage transfer after extended culture to Day 5/6 was less common until culture media systems were improved. Routine use of PGS for IVF/ICSI cycles to deselect aneuploid cleavage stage embryos has been shown to be unreliable and even reduce pregnancy rates (Gleicher and Barad 2012) due to mosaicism of embryos at this stage. The following parameters are currently most widely used in Day 2 and Day 3 grading schemes.


Table 25.3 Recommended timings for cleavage stage Day 2 and Day 3 embryo assessment (Alpha/ESHRE Istanbul Consensus 2011).
















Observation Timing (Hours Postinsemination) Expected Stage Of Development
Day 2 assessment 44 ± 1 h Four‐cell stage
Day 3 assessment 68 ± 1 h Eight‐cell stage

Cell Number/Cleavage Rate

The single most important indicator of embryo viability is the occurrence of cellular division. The ideal cleavage was found to be four cells on Day 2 and eight cells on Day 3, with a markedly lower implantation potential for embryos below that and, to a lesser degree above that (Holte et al. 2007) and is in general agreement with previous observations (Van Royen et al. 1999; Magli et al. 2001). A correlation between ‘normal cell number’ and chromosomal constitution has also been reported (Almeida and Bolton 1996; Magli et al. 2007).


Fragmentation

Mitotic division of embryos can lead to externalization of parts of the cell cytoplasm, resulting in the presence of anuclear fragments surrounded by a plasma membrane (Antczak and van Blerkom 1999). Presence of fragmentation is common in human embryos and assessment has been used in almost all embryo scoring systems. Severe fragmentation of the embryo is associated with poor prognosis (Ziebe et al. 1997; Van Royen et al. 1999, 2001).


As well as the percentage of fragmentation in the embryo, fragment size and distribution has been shown to correlate with the probability of implantation (Alikani et al. 2000; Ebner et al. 2001; Van Blerkom et al. 2001). However, it is often unclear how to differentiate fragments from cells and then estimate the relative proportion of the embryo that is fragmented. Large fragments, sometimes resembling whole cells, often distributed randomly, are associated with uneven cells and produced a low implantation rate in some studies (Alikani and Cohen 1995). The loss of important cytoplasmic content, such as cell organelles, proteins, or mRNA may leave cells in largely fragmented embryos too small to be biologically competent (Johansson et al. 2003; Hnida et al. 2004).


The size of fragmented cells has been defined as <45 mm in diameter for Day 2 embryos, and <40 mm in diameter for Day 3 embryos (Johansson et al. 2003; Alpha/ESHRE Istanbul Consensus 2011). As mentioned earlier, these findings may influence scoring criteria; embryos previously scored with uneven‐sized cells might now be scored as partially fragmented embryos. However, it is not easy to measure the size of fragments routinely, and use of TLI may reduce subjectivity.


The presence of small, scattered fragments (10–20%) does not appear to impair further development (Van Royen et al. 1999; Hardarson et al. 2001; Racowsky et al. 2003) and these may disappear through lysis or resorption during culture (Hardarson et al. 2001). Thus, a low degree of fragmentation may be normal and may suggest apoptotic elimination of selected cells in an effort to restore or maintain viability when anomalies are present (Ziebe 1997; Alikani et al. 2000). It is also possible that these fragments are generated during successive divisions and are simply a product of imperfect cytokinesis rather than a specific anomaly.


Cell Size/Cleavage Evenness

When undergoing the first mitotic cell divisions, a zygote cleaving synchronously and symmetrically will present two, four, or eight cells of a similar size. Cells of equal size appear to be another indicator of implantation potential (Steer et al. 1992; Hardarson et al. 2001; Hnida et al. 2004; Paternot et al 2013). For all other early cleavage stages of three, five, six, seven, and nine cells, a size difference in the cells would be expected as the cleavage phase has not been completed (Scott 2001; Magli et al. 2012).


Several studies have identified the phenomenon of uneven cleavage leading to unequal cell size, and this is commonly found in IVF embryos. Unevenly sized cells have also been shown to have an increased prevalence of chromosomal abnormalities (Hardarson et al. 2001; Magli et al. 2001: Ziebe et al. 2003), including multinucleation (Hardarson et al. 2001). The latter study suggested that early cleavage may be hindered by the presence of aneuploidy delaying the cell cycle. This impairment may also be due to uneven distribution of proteins, mRNA, mitochondria, and furthermore may possibly disturb the polarized allocation of certain proteins and genes in both oocytes and embryos (Antczak and Van Blerkom 1999).


However, there are difficulties with routine microscopic assessment as cells scored as unevenly cleaved may actually be large anucleate fragments. As mentioned above in the section on fragmentation, embryos with uneven‐sized cells might be scored as partially fragmented embryos and vice‐versa. This will in turn also affect the reliability of the cell count assessment, e.g. an embryo scored as an uneven eight‐cell may actually be a fragmented six‐cell embryo. TLI may be used as a tool to improve reliability of assessment allowing quantitative measurement.


Multinucleation

A cell containing more than a single interphase nucleus, is defined as being multinucleated (MN) and considered abnormal. A negative impact on the implantation potential of MN embryos has been observed (Van Royen et al. 2003; Saldeen and Sundstrom, 2005) and has been correlated with a high degree of chromosomal aberration (Kligman et al. 1996; Hardarson et al. 2001) with MN cells being significantly larger than nonnucleated cells (Hnida et al. 2004).


However, it was shown that among embryos in which both cells were bi‐ or multinuclear at the two‐cell stage, 30% had only mononuclear cells following cleavage (Staessen and Van Steirteghem 1998). Thus, some MN cells still seem to be able to cleave normally (Meriano et al. 2004).


Factors that have been suggested to affect the rate of MN include culture media (Winston et al. 1991), and poor temperature control especially in relation to oocyte retrieval (Pickering et al. 1990). Different mechanisms leading to MN cells have been suggested including the dissociation of karyokinesis from cytokinesis, partial fragmentation of the nucleus, or defective migration of chromosomes at mitotic anaphase (Munne and Cohen 1993; Staessen and Van Steirteghem 1998). Fluorescence in situ hybridization (FISH) demonstrated that all these mechanisms may be involved.


Grading Schemes for Selection of Cleavage Stage Embryos


In the UK, a standardized grading scheme (Cutting et al. 2008; Table 25.4) is used by the External Quality Assessment Scheme (UK NEQAS) for Embryology, launched in 2009. This grading scheme was presented in 2011 at the Istanbul Consensus meeting by Daniel Brison and endorsed the NICE Fertility Guidelines (2013). The grading scheme has recently been reviewed by an ACE working party in consultation with the ACE membership and UK NEQAS Reproductive Science (Critchlow et al. 2016). The amended grading scheme was released by ACE in January 2017 and adopted by the UK NEQAS Scheme for Embryology in April 2017. ACE and NEQAS have agreed that all embryos should be graded in a stage‐specific way (Table 25.5). This is particularly relevant for those embryos that are naturally asynchronous, such as those with three, five and seven blastomeres.


Table 25.4 UK National Grading Scheme for Day 2 and Day 3 cleavage stage embryo assessment.


Source: Cutting et al. (2008).









Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 3, 2020 | Posted by in EMBRYOLOGY | Comments Off on Morphological Assessment of Embryos in Culture

Full access? Get Clinical Tree

Get Clinical Tree app for offline access
Blastomere Number
Blastomere size